Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome.

Schweizer E, Rickels K, Case WG, Greenblatt DJ.

Arch Gen Psychiatry. 1991 May;48(5):448-52.

PMID:
2021297
2.

Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation.

Rickels K, Schweizer E, Case WG, Greenblatt DJ.

Arch Gen Psychiatry. 1990 Oct;47(10):899-907. Erratum in: Arch Gen Psychiatry 1991 Jan;48(1):51.

PMID:
2222129
3.

Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper.

Schweizer E, Rickels K, Case WG, Greenblatt DJ.

Arch Gen Psychiatry. 1990 Oct;47(10):908-15.

PMID:
2222130
4.

Prior benzodiazepine exposure and benzodiazepine treatment outcome.

Rickels K, Freeman EW.

J Clin Psychiatry. 2000 Jun;61(6):409-13.

PMID:
10901337
5.
7.

Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.

Wichniak A, Brunner H, Ising M, Pedrosa Gil F, Holsboer F, Friess E.

Psychoneuroendocrinology. 2004 Oct;29(9):1101-8.

PMID:
15219633
8.

Withdrawal reaction after long-term therapeutic use of benzodiazepines.

Busto U, Sellers EM, Naranjo CA, Cappell H, Sanchez-Craig M, Sykora K.

N Engl J Med. 1986 Oct 2;315(14):854-9.

PMID:
3092053
9.

Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.

Rickels K, DeMartinis N, García-España F, Greenblatt DJ, Mandos LA, Rynn M.

Am J Psychiatry. 2000 Dec;157(12):1973-9.

PMID:
11097963
10.

In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods.

McGregor C, Machin A, White JM.

Drug Alcohol Rev. 2003 Jun;22(2):175-80.

PMID:
12850904
11.

Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome.

Rickels K, Schweizer E, Garcia España F, Case G, DeMartinis N, Greenblatt D.

Psychopharmacology (Berl). 1999 Jan;141(1):1-5.

PMID:
9952057
12.

Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings.

Denis C, Fatséas M, Lavie E, Auriacombe M.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005194. Review. Update in: Cochrane Database Syst Rev. 2013;6:CD005194.

PMID:
16856084
13.

Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.

Rickels K, Schweizer E, Weiss S, Zavodnick S.

Arch Gen Psychiatry. 1993 Jan;50(1):61-8.

PMID:
8422223
14.

Imipramine and buspirone in patients with panic disorder who are discontinuing long-term benzodiazepine therapy.

Rynn M, García-España F, Greenblatt DJ, Mandos LA, Schweizer E, Rickels K.

J Clin Psychopharmacol. 2003 Oct;23(5):505-8.

PMID:
14520129
15.

The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.

Zhang ZJ, Kang WH, Li Q, Tan QR.

J Psychiatr Res. 2007 Nov;41(10):828-36. Epub 2006 Sep 29.

PMID:
17010995
16.

Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.

Small GW, Bystritsky A.

J Clin Psychiatry. 1997;58 Suppl 11:24-9.

17.

The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.

Mercier-Guyon C, Chabannes JP, Saviuc P.

Curr Med Res Opin. 2004 Sep;20(9):1347-55.

PMID:
15383182
18.

A double-blind placebo-controlled study of buspirone in diazepam withdrawal in chronic benzodiazepine users.

Ashton CH, Rawlins MD, Tyrer SP.

Br J Psychiatry. 1990 Aug;157:232-8.

PMID:
2224374
20.

[Benzodiazepine withdrawal with carbamazepine].

Kaendler SH, Volk S, Pflug B.

Nervenarzt. 1996 May;67(5):381-6. German.

PMID:
9005346

Supplemental Content

Support Center